+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization

  • PDF Icon

    Report

  • 356 Pages
  • August 2022
  • Region: Global
  • Howe Sound Research
  • ID: 5275068

Will Diagnostics Solve the Problem? Multiple Diagnostic Technologies Create New Global Race

Report Overview:

Diagnostics are leading the charge in reducing the threat posed by antimicrobial resistance. Will these technologies solve the problem before new antibiotics come along? New diagnostic technologies, beyond gene sequencing, are under development to capture this growing market.

The publisher has looked at the technology picture, giving you a plain language understanding of the different ways pathogens, and infections can be diagnosed. The report has identified the 6 Key Large Pathogen Opportunities in this space and developed market forecasts. We profile over 30 companies, large and small, working in this area.

Make investment decisions and valuations with confidence using the latest data.

The report includes five-year market forecasts.

Table of Contents

1 Market Guides
1.1 Antimicrobial Resistance - Strategic Situation Analysis
1.2 Guide for Executives and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
2.1 The Threat and Opportunity of Antimicrobial Resistance
2.2 Defining the Opportunity
2.2.1 Revenue Market Size
2.3 Methods and Sources
2.3.1 Methodology
2.3.2 Sources
2.3.3 Authors
2.4 U.S. Antibiotic Markets - Perspective
2.4.1 U.S. Outpatient Use of Antibiotics
2.4.2 U.S. Pharmaceutical Spending
3 Overview of a Dynamic Market
3.1 Market Players - Roles & Impacts
3.1.1 Drug manufacturers - Larger/pharmaceutical
3.1.2 Drug manufacturers - Generic
3.1.3 Contract Research and Manufacturing
3.1.4 In Vitro Diagnostics Industry
3.1.5 Drug Marketing Companies
3.1.6 Biotechnology Companies
3.1.7 Regulatory Bodies
3.2 Understanding Antimicrobial Resistance
3.2.1 What is Antimicrobial Resistance (AMR)
3.2.2 Bacteria and Other Microbes
3.2.3 The History of Antibiotics
3.2.4 The Role of Animal Husbandry
3.2.5 The Implications of Horizontal Transfer
3.2.6 The Threat of AMR
3.3 The Changing Road to New Antibiotics & Technologies
3.4 The Key Role of Diagnostics in AMR
4 The Market Opportunity of AMR
4.1 The Key Large Market Opportunities in AMR
4.1.1 Streptococcus Pneumoniae (DRSP)
4.1.2 Campylobacter (DRC)
4.1.3 Clostridium Difficile (CD)
4.1.4 Staphylococcus aureus (MRSA)
4.1.5 Neisseria gonorrhoeae (DRNG)
4.1.6 Salmonella (DRNTS)87
4.2 Diagnostic Technology Development Opportunities
4.2.1 What’s Wrong with Microbiology
4.2.2 The Features Battleground of Infectious Disease Diagnostics
4.2.3 Multiplex vs. POC/Rapid
4.2.4 The Miracle of Genetics
4.2.5 From Multiple Pathogens to All Pathogens - The Next Next Generation
4.2.6 Gene Sequence Diagnostics WITHOUT Sequencing
4.2.7 Markers of Resistance.
4.2.8 What Happens to the Microbiology Lab?
5 Antibiotic Resistance Diagnostics Recent Developments
5.1 Antibiotic Resistance Recent Developments
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
5.2 T2 Biosystems Exercises BARDA Option
5.3 OpGen to Ramp up Use of Acuitas AMR Gene Panel
5.4 BD Partners With Pfizer, Wellcome to Study AMR Dx
5.5 Sepsis Test Developers Accelerate Plans
5.6 OpGen Receives FDA Clearance for AMR Panel
5.7 Visby Medical - Rapid Uptake of Handheld PCR Test for STIs
5.8 MicroGenDx, OrthoKey Clinic and OrthoKey Surgery
5.9 BioMérieux Receives CE Mark for Vitek Clinical Microbiology System
5.10 Hologic to Acquire Mobidiag
5.11 Campylobacter strains exchange genes
5.12 Disinfection spreads antimicrobial resistance
5.13 Molzym, Fraunhofer Developing Rapid Sepsis Dx
5.14 Illumina, IDbyDNA Build NGS-Based Respiratory Panel
5.15 Accelerate Diagnostics Expands AMR Testing
5.16 Rapid diagnostics linked to optimal antibiotics
5.17 Visby Medical Wins AMR Diagnostic Competition
5.18 DNAe Technology SARS-CoV-2 Sequences
5.19 Infections with foodborne bacteria becoming harder to treat
5.20 Dust is sharing antibiotic resistance genes
5.21 Report predicts drug resistance likely to kill 400,000
5.22 New method to test for infection resistance.
5.23 Qiagen launches AMR database
5.24 Antibiotic resistance test for gonorrhea gets FDA breakthrough
5.25 Qiagen, Ares Genetics Ink Licensing Pact for AMR Bioinformatics
6 Key AMR Diagnostics Companies
6.1 1928 Diagnostics
6.2 Abacus Diagnostica
6.3 Abbott Laboratories
6.4 Accelerate Diagnostics
6.5 ADT Biotech
6.6 Beckman Coulter Diagnostics
6.7 Becton, Dickinson and Company
6.8 Binx Health
6.9 bioMérieux Diagnostics
6.10 Bio-Rad Laboratories, Inc.
6.11 Cepheid (Danaher)
6.12 Curetis N.V./Curetis GmbH
6.13 Day Zero Diagnostics
6.14 Enzo Biochem
6.15 Eurofins Scientific
6.16 Fusion Genomics
6.17 GeneFluidics
6.18 Great Basin Corporation
6.19 Hologic
6.20 Hutman Diagnostics
6.21 Inflammatix
6.22 Linear Diagnostics
6.23 Lumos Diagnostics
6.24 Millipore Sigma
6.25 OpGen
6.26 Ortho Clinical Diagnostics
6.27 Perkin Elmer
6.28 Qiagen
6.29 Roche Molecular Diagnostics
6.30 SeLux Diagnostics
6.31 Sense Biodetection
6.32 Siemens Healthineers
6.33 Sysmex
6.34 Thermo Fisher Scientific Inc.
6.35 Visby Medical
7 The Global Market for Antimicrobial Resistance Diagnostics
7.1 Global Market Overview by Country
7.1.1 Table - Global Market by Country
7.1.2 Chart - Global Market by Country
7.2 Global Market by Technology - Overview
7.2.1 Table - Global Market by Pathogen
7.2.2 Chart - Global Market by Pathogen - Base/End Year Comparison
7.2.3 Chart - Global Market by Pathogen - Base Year
7.2.4 Chart - Global Market by Pathogen - End Year
7.2.5 Chart - Global Market by Pathogen - Share by Year
7.2.6 Chart - Global Market by Pathogen - Segment Growth
7.3 Global Market by Technology - Overview230
7.3.1 Table - Global Market by Technology
7.3.2 Chart - Global Market by Technology - Base/End Year Comparison
7.3.3 Chart - Global Market by Technology - Base Year
7.3.4 Chart - Global Market by Technology - End Year
7.3.5 Chart - Global Market by Technology - Share by Year
7.3.6 Chart - Global Market by Technology - Segment Growth
8 Global Antibiotic Resistance Diagnostic Markets - By Pathogen
8.1 Drug Resistant Streptococcus Pneumoniae - DRSP
8.1.1 Table DRSP - by Country
8.1.2 Chart - DRSP Growth
8.2 Drug Resistant Campylobacter - DRC
8.2.1 Table DRC - by Country
8.2.2 Chart - DRC Growth
8.3 Clostridium Difficile - CD
8.3.1 Table CD - by Country
8.3.2 Chart - CD Growth
8.4 Methicillin Resistant Staphylococcus Aureus - MRSA
8.4.1 Table MRSA - by Country
8.4.2 Chart - MRSA Growth
8.5 Drug Resistant Neisseria Gonorrhoeae - DRNG
8.5.1 Table DRNG - by Country
8.5.2 Chart - DRNG Growth
8.6 Drug Resistant Salmonella - DRNTS
8.6.1 Table DRNTS - by Country
8.6.2 Chart - DRNTS Growth

9 Global Antibiotic Resistance Diagnostic Markets - by Technology
9.1 Microbiology Culture
9.1.1 Table Culture - by Country
9.1.2 Chart - Culture Growth
9.2 Immunoassay
9.2.1 Table Immunoassay - by Country
9.2.2 Chart - Immunoassay Growth
9.3 PCR
9.3.1 Table PCR - by Country
9.3.2 Chart - PCR Growth
9.4 NGS
9.4.1 Table NGS - by Country
9.4.2 Chart - NGS Growth
9.5 Mass Spectrometry - MS
9.5.1 Table MS - by Country
9.5.2 Chart - MS Growth
9.6 Rapid and Point of Care - Rapid/POC
9.6.1 Table Rapid/POC - by Country
9.6.2 Chart - Rapid/POC Growth
10 Vision of the Future of AMR Diagnostics
11 Appendices
11.1 United States Medicare System: 2022 Clinical Laboratory Fees Schedule
Table of Tables
Table 1 USA - Outpatient Use of Antibiotics by Class
Table 2 USA - Outpatient Use of Antibiotics Top 5
Table 3  Market Players by Type
Table 4  Known Human Pathogenic Diseases
Table 5 The Key Market Opportunities
Table 6 - Market Potential DRSP Diagnostic
Table 7 - Market Potential DRC Diagnostic
Table 8 - Market Potential CD Diagnostic
Table 9 - Market Potential CD Diagnostic
Table 10 Market Potential DRNG Diagnostic
Table 11 Market Potential DRNTS Diagnostic
Table 12 - Key AMR Diagnostics Issues
Table 13 - Global Market by Region
Table 14 Global Market by Pathogen
Table 15 Global Market by Technology
Table 16 DRSP by Country
Table 17  DRC by Country
Table 18 CD by Country
Table 19 MRSA by Country
Table 20 DRNG by Country
Table 21 DRNTS by Country
Table 22  Culture by Country
Table 23 Immunoassay by Country
Table 24  PCR by Country
Table 25  NGS by Country
Table 26  MS by Country
Table 27  Rapid/POC by Country
Table 28 2022 Clinical Lab Fee Schedule
List of Figures
Figure 1 Pharmaceutical Spending History by Country
Figure 2 AMR and Antibiotic Introduction
Figure 3 The Death Toll of AMR
Figure 4 Global Market Share Chart
Figure 5 Global Market by Pathogen - Base vs. End Year
Figure 6 Global Market by Pathogen Base Year
Figure 7 Global Market by Pathogen End Year
Figure 8 Pathogen Share by Year
Figure 9 Pathogen Segment Growth
Figure 10 Technology - Base vs. End Year Segment Shift
Figure 11 Technology Market Base Year
Figure 12 Technology Market End Year
Figure 13 Technology Share by Year
Figure 14 Technology Segment Growth
Figure 15 DRSP Growth
Figure 16 DRC Diagnostics Growth
Figure 17 CD Growth
Figure 18 MRSA Growth
Figure 19 DRNG Growth
Figure 20 DRNTS Growth
Figure 21 Culture Growth
Figure 22 Immunoassay Growth
Figure 23 PCR Growth
Figure 24 NGS Growth
Figure 25 MS Growth
Figure 26 Rapid/POC Growth

Companies Mentioned

  • 1928 Diagnostics
  • Abacus Diagnostica
  • Abbott Laboratories
  • Accelerate Diagnostics
  • ADT Biotech
  • BD Partners
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company  
  • Binx Health
  • Bio-Rad Laboratories, Inc.
  • BioMérieux
  • bioMérieux Diagnostics
  • Cepheid (Danaher)
  • Curetis N.V./Curetis GmbH
  • Day Zero Diagnostics 
  • Enzo Biochem
  • Eurofins Scientific  
  • Fusion Genomics
  • GeneFluidics  
  • Great Basin Corporation
  • Hologic
  • Hutman Diagnostics
  • Illumina
  • Inflammatix
  • Linear Diagnostics
  • Lumos Diagnostics
  • MicroGenDx
  • Millipore Sigma  
  • Molzym GmbH & Co. KG
  • OpGen 
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Pfizer 
  • Qiagen
  • Qiagen 
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Sense Biodetection  
  • Siemens Healthineers
  • Sysmex
  • T2 Biosystems 
  • Thermo Fisher Scientific Inc.
  • Visby Medical 

Methodology

Loading
LOADING...